High prescription drug costs mean approximately 45 million adults in the U.S., or 18 percent of Americans over the age of 18, did not fill a prescription last year, according to the nonprofit group Prescription Justice.. Read More »
Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York. Read More »
The U.S. Food and Drug Administration approved Amgen's Parsabiv for the treating of secondary hyperparathyroidism in adults with chronic kidney failure and is administered at dialysis locations throughout the country. Read More »
Portola Pharmaceuticals cleared a U.S. Food and Drug Administration mid-cycle review for its new drug Betrixaban, meaning the drug will not have to go before an advisory committee at this stage. Read More »
A U.S. appeals court suspended a permanent injunction on Praluent, a cholesterol management drug, allowing Regeneron Pharmaceuticals to once again manufacture, market, sell and ship the drug around the world. Read More »
The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »
PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »
Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »
The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »
Pharmaceutical companies, trial lawyers and tort reform advocates are closely following a case that the U.S. Supreme Court has taken up that addresses the issue of plaintiffs joining suits in other states. Read More »
The sPCMA Business Forum will be held March 8-9, providing valuable information into specialty drug benefit management, specialty pharmacies, drug manufacturers and related topics. Read More »
Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin. Read More »
The Center for Medicaid and CHIP Services is encouraging pharmacies to extend the scope of dispensing medications to foster immediate access to certain drugs. Read More »
i-Health Inc. is moving toward the acquisition of UP4 Probiotics from UAS Laboratories LLC in an arrangement the company believes will help it become a leader in the probiotic world. Read More »
The recent National Association of Chain Drug Stores Regional Chain Conference in Palm Beach, Florida addressed the important role of pharmacies in this country amid possible changes under President Donald Trump's administration. Read More »
Pfizer Inc. has partnered with relationship expert Logan Levkoff to host a Q&A session on relationship and intimacy advice for people dealing with chronic diseases. Read More »
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference this year. Read More »
Sanofi, a global leader in health care and medication distribution, has received FDA approval of Xyzal Allergy 24HR as an over-the-counter medicine. Read More »
The Advisory Committee on Immunization Practices, an extension of the Centers for Disease Control, recommends not using the live influenza vaccine due to poor efficacy. Read More »
The U.S. House of Representative recently passed legislation that increases the role of pharmacists in patient needs by expanded the services that pharmacies offer. Read More »
Alerts Sign-up